You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CARDIZEM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Cardizem patents expire, and what generic alternatives are available?

Cardizem is a drug marketed by Biovail, Biovail Labs Intl, and Bausch. and is included in six NDAs.

The generic ingredient in CARDIZEM is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-two suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Cardizem

A generic version of CARDIZEM was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CARDIZEM?
  • What are the global sales for CARDIZEM?
  • What is Average Wholesale Price for CARDIZEM?
Summary for CARDIZEM
Drug patent expirations by year for CARDIZEM
Drug Prices for CARDIZEM

See drug prices for CARDIZEM

Recent Clinical Trials for CARDIZEM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Assiut UniversityEarly Phase 1
CAMC Health SystemPhase 4
University of South FloridaN/A

See all CARDIZEM clinical trials

Pharmacology for CARDIZEM

US Patents and Regulatory Information for CARDIZEM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Biovail CARDIZEM diltiazem hydrochloride INJECTABLE;INJECTION 020792-001 Sep 5, 1997 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM LA diltiazem hydrochloride TABLET, EXTENDED RELEASE;ORAL 021392-006 Feb 6, 2003 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-004 Dec 8, 1986 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-001 Nov 5, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-005 Aug 24, 1999 AB3 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Biovail CARDIZEM SR diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019471-002 Jan 23, 1989 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM CD diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020062-001 Aug 10, 1992 AB3 RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for CARDIZEM

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-004 Dec 8, 1986 ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-001 Nov 5, 1982 ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-003 Dec 8, 1986 ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-004 Dec 8, 1986 ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-002 Nov 5, 1982 ⤷  Sign Up ⤷  Sign Up
Bausch CARDIZEM diltiazem hydrochloride TABLET;ORAL 018602-004 Dec 8, 1986 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for CARDIZEM

See the table below for patents covering CARDIZEM around the world.

Country Patent Number Title Estimated Expiration
Netherlands 6815390 ⤷  Sign Up
Germany 1160981 Verfahren zur Gewinnung von kristallisiertem PGE und PGF ⤷  Sign Up
Sweden 305869 ⤷  Sign Up
Sweden 337887 ⤷  Sign Up
Denmark 129336 ⤷  Sign Up
Australia 465150 ⤷  Sign Up
Spain 359545 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.